Entering text into the input field will update the search result below
Join now
Search for Symbols, analysts, keywords
Log in
FTSV
Forty Seven, Inc.
Stock Price & Overview
Follow
FTSV is defunct since March 10, 2019.
Summary
All
Analysis
News
Transcripts
SEC Filings
Related Analysis
Analysis
See All Analysis »
News
Latest Headlines
All
Articles
News
Gilead completes Forty Seven buy
Gilead nearing finish line on Forty Seven buy
Forty Seven EPS beats by $0.10
Forty Seven teams up with Rocket Pharma in rare pediatric anemia
Gilead takes out Forty Seven for $4.9B
Trillium +44% after report of possible Forty Seven takeover
Gilead Sciences approaches Forty Seven with takeover deal - Bloomberg
Forty Seven (FTSV) Investor Presentation - Slideshow
Key events next week - healthcare
Forty Seven Validates CD47 With 'Don't Eat Me' Tech, Pivotal Studies To Be Initiated In 2020
More News And Analysis »
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
